REQUEST FOR PRE-PROPOSALS – Far Forward Biological Sequencing (Increment 2) for JPEO CBRND; Automated Sample Prep
ID: W911SR-26-R-FFBSType: Presolicitation
Overview

Buyer

DEPT OF DEFENSEDEPT OF THE ARMYW6QK ACC-APGABERDEEN PROVING GROU, MD, 21010-5424, USA

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

PSC

NATIONAL DEFENSE R&D SVCS; DEPARTMENT OF DEFENSE - MILITARY; R&D FACILITIES & MAJ EQUIP (AC15)

Set Aside

No Set aside used (NONE)

Original Source

https://sam.gov/workspace/contract/opp/23a6afb89df04f4a99c767593eccdc57/view
Timeline
    Description

    The Department of Defense, through the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND), is soliciting pre-proposals for the Far Forward Biological Sequencing (FFBS) Increment 2 project, which aims to develop an automated biological identification system capable of detecting various Biological Warfare Agents (BWAs). The objective is to create a system that achieves a Technology Readiness Level (TRL) of seven or higher within 24 months, incorporating automated sample preparation, a nanopore sequencing device, and bioinformatics software, all operable by non-laboratory trained users in field environments. This initiative addresses critical gaps in current biological identification capabilities for military personnel in far-forward settings, enhancing their safety and operational effectiveness. Interested vendors must submit their pre-proposals by December 8, 2025, and can direct inquiries to Jessica R. Green-Farley at jessica.r.green-farley.civ@army.mil or Tyler N. Gates at tyler.n.gates2.civ@army.mil.

    Files
    Title
    Posted
    FFBS Inc2 PWS_25Nov25.pdf
    The Far Forward Biological Sequencing (FFBS) program, managed by JPM CBRN SOF within the DoD, aims to develop and field a biological identification system for Special Operations Forces. This system will identify known and unknown biological warfare agents, addressing current limitations in far-forward environments. The program will leverage existing technology transition agreements for automated DNA/RNA sample preparation and advanced bioinformatics. This Other Transaction Agreement (OTA) focuses on developing a prototype FFBS Increment 2 system during the Technology Maturation and Risk Reduction (TMRR) phase, with an option for the Engineering and Manufacturing Development (EMD) phase. The prototype, to achieve a TRL of 7 or better within 24 months, will feature automated sample preparation, a nanopore sequencing device, and bioinformatics software, operable by non-laboratory trained users in field environments. The document details extensive requirements across program management, systems engineering, testing (TMRR and EMD), and integrated product support, adhering to numerous military and DoD standards.
    INCR2_BOTAA_NOTICE_112425_v3_FINAL.pdf
    The Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND) seeks pre-proposals for Far Forward Biological Sequencing (FFBS) Increment 2: Automated Sample Prep. The objective is to develop a system to identify numerous Biological Warfare Agents (BWAs) with a Technology Readiness Level (TRL) of seven or higher within 24 months. This system will include an automated sample and library preparation device compatible with nanopore sequencing, a custom computing element, and bioinformatics software, operable in far-forward field environments by non-laboratory trained users. The program aims to award an Other Transaction Agreement (OTA) for prototype development during the Technology Maturation and Risk Reduction (TMRR) phase, with an option for the Engineering and Manufacturing Development (EMD) phase. The deadline for pre-proposals is December 8, 2025.
    Similar Opportunities
    JPEO-CBRND RFI - Genomic Sequencing Workflows
    Buyer not available
    The Department of Defense's Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND) is issuing a Request for Information (RFI) to gather insights on end-to-end untargeted genomic sequencing workflows suitable for military applications. The RFI seeks to identify industry capabilities in developing genomic sequencing workflows, field-deployable bioinformatics tools, test and evaluation infrastructure, and protein toxin sequencing capabilities, all tailored for military users with varying technical expertise. This initiative is crucial for enhancing military readiness and response to biological threats through advanced genomic technologies. Interested parties are invited to submit their responses by January 9, 2026, with an Industry Day scheduled for January 29, 2026, at the SPA, Crown Center Conference Facility in Lorton, VA. For more information and to respond, please visit the Joint Enterprise Technology Tool (JETT) page.
    JPEO-CBRND RFI - Innovation in Biologics Manufacturing
    Buyer not available
    The Department of Defense, through the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND), is issuing a Request for Information (RFI) focused on innovations in biologics manufacturing. This RFI seeks information on capabilities and technologies related to biologics manufacturing, specifically targeting cell-free production capabilities, advancements in process control, and methods to expedite drug substance release. The initiative aims to enhance medical solutions for crisis response and improve preparedness against future threats. Interested parties are encouraged to share their capabilities via the Joint Enterprise Technology Tool (JETT) platform, with no commitment from the government to issue a subsequent Request for Proposal (RFP).
    Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (CBRND) Operational Support (JCOS)
    Buyer not available
    The Department of Defense, specifically the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO CBRND), is seeking operational support services through a Request for Information (RFI) for the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JCOS). The objective is to transition from reliance on external consultants to integrated operational support, enhancing capabilities in areas such as Test & Evaluation, Strategic Communications, and CBRN Medical Support, in alignment with Executive Order 14222 aimed at improving government efficiency. This initiative is critical for bolstering the Department's ability to manage defense capabilities against CBRN threats, with a contract period starting from March 23, 2026, through March 22, 2031, including a base year and four option years. Interested parties must submit their responses by 5 p.m. ET on December 9, 2025, to the primary contact, Peter W. Stahley, at peter.w.stahley.civ@army.mil, or the secondary contact, Eric Y. Jun, at eric.y.jun.civ@army.mil.
    JPEO-CBRND CWMD BOTAA-24-01
    Buyer not available
    Special Notice DEPT OF DEFENSE DEPT OF THE ARMY: The Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND) is seeking funding through Other Transaction Authority agreements (OTAs) for prototype and follow-on production projects within JPEO-CBRND mission areas of interest. The service being procured is the development of enabling technologies that speed up the advanced development process. This opportunity is open to all eligible sources, including educational institutions, nonprofit organizations, and private industry. Proposals are to be submitted in accordance with the provided guidelines. For more information, please refer to the JPEO-CBRND website.
    Chemical Biological Mask Equipment Tester (CBMET) Modernization Effort
    Buyer not available
    The Department of Defense, specifically the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND), is soliciting pre-proposals for the modernization of the Chemical Biological Mask Equipment Tester (CBMET) portfolio. The objective is to develop a consolidated testing solution that assesses mask fit and serviceability for current and future CBRN protective masks, addressing issues of obsolescence and material shortages. This initiative is critical for enhancing military personnel's mission effectiveness and defense capabilities against Weapons of Mass Destruction (WMD). Interested parties must submit their pre-proposals electronically to the designated contacts by 5:00 PM EST on December 22, 2025, with further inquiries directed to the provided email addresses.
    BROAD AGENCY ANNOUNCEMENT (BAA) RESEARCH AND DEVELOPMENT IN SUPPORT OF THE JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL AND NUCLEAR DEFENSE (JPEO-CBRND), JPM MEDICAL AND JPL EB
    Buyer not available
    Solicitation DEPT OF DEFENSE is seeking research and development services in support of the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND), JPM Medical and JPL EB. The service being procured is for the identification of the best available science in the areas of research interest, including novel solutions and improved methods for developing medical countermeasures. The government is specifically interested in enabling technologies, life cycle bioinformatics, and improved logistics tracking. The procurement notice is available on SAM.gov and the JPEO-CBD website. Potential offerors are encouraged to communicate with the JPMO technical contacts for proposal ideas. For any questions or inquiries, contact usarmy.detrick.mcs.mbx.baa@mail.mil.
    BROAD AGENCY ANNOUNCEMENT (BAA) FOR CHEMICAL BIOLOGICAL RADIOLOGICAL NUCLEAR AND EXPLOSIVE (CBRNE) DEFENSE EFFORTS UNDER PROCUREMENT CONTRACTS, COOPERATIVE AGREEMENTS, AND PROTOTYPES UNDER OTHER TRANSACTIONS AGREEMENTS
    Buyer not available
    The Department of Defense, specifically the U.S. Army Combat Capabilities Development Command Chemical Biological Center (DEVCOM CBC), has issued a Broad Agency Announcement (BAA) to solicit proposals for innovative research and development in chemical, biological, radiological, nuclear, and explosive (CBRNE) defense capabilities. This solicitation is open continuously for up to five years and invites proposals from educational institutions, nonprofit organizations, and private industry, focusing on areas such as detection technologies, modeling and simulation, and countermeasures to terrorism. The BAA is crucial for enhancing national defense capabilities and ensuring the Joint Warfighters' dominance on the battlefield and homeland defense. Interested parties can contact Marc Lukaszewicz at marc.s.lukaszewicz.civ@army.mil or Lionel Love at lionel.d.love.civ@army.mil for further information regarding proposal submissions and evaluation criteria.
    JPEO-CBRND RFI - Wearable CBRN Threat Monitoring Sensors
    Buyer not available
    The Department of Defense, through the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND), is seeking information on wearable CBRN threat monitoring sensors as part of a Request for Information (RFI). The objective is to gather insights on technologies capable of real-time monitoring of various physiological and environmental parameters, including vital signs, cognitive performance, and exposure to chemical, biological, radiological, and nuclear threats, while maintaining low size, weight, and power attributes. These sensors are crucial for enhancing operational safety and effectiveness in environments where CBRN threats may be present. Interested parties are encouraged to submit white papers and technical briefs detailing their capabilities, with responses to be submitted via the Joint Enterprise Technology Tool (JETT) platform. This RFI is for information and planning purposes only, and no funding amount or contract award timeline has been specified.
    BATTLEFIELD WOUND INFECTION PREVENTION AND TREATMENT (BWI P&T): BARRIER COMBINATION PRODUCT DEVELOPMENT
    Buyer not available
    The Department of Defense, through the Defense Health Agency (DHA), is conducting market research for the development of a barrier combination product aimed at preventing and treating battlefield wounds and subsequent infections. This initiative, part of the Battlefield Wound Infection Prevention and Treatment (BWI P&T) program, seeks to identify commercial solutions that can effectively address the unique challenges of wound care in austere environments, where medical resources may be limited. The barrier combination product is expected to play a crucial role in a Family of Systems (FoS) approach, providing innovative solutions for both military and commercial applications in wound care. Interested parties are invited to submit their responses by January 20, 2026, at 2:00 PM Eastern, via email to the primary contacts, Jeanette Collins and Julie Burns, whose emails are provided in the opportunity overview. This RFI is for planning purposes only, and no contract will be awarded based on the responses received.
    NAWCWD Broad Agency Announcement
    Buyer not available
    The Department of Defense, through the Naval Air Warfare Center Weapons Division (NAWCWD), has issued a Broad Agency Announcement (BAA) for research and development in biotechnology, specifically excluding nanobiotechnology. This opportunity invites proposals for innovative solutions that align with the objectives outlined in the Federal Acquisition Regulation and the Department of Defense Grants and Agreements Regulations, emphasizing that no formal Request for Proposal will be issued. The BAA is critical for advancing national defense capabilities, and NAWCWD retains the discretion to fund all, some, or none of the proposals submitted, with no reimbursement for proposal development costs. Interested parties can direct inquiries to Julie Dack at julie.j.dack.civ@us.navy.mil or call 760-793-3752 for further information.